Viewing entries posted in 2011
NHS National Innovation Centre estimates Sequana Medical’s alfapump® system could save the NHS £50 million in ascites care annually
NHS National Innovation Centre supports the cost effectiveness of Sequana Medical’s ALFApump System.
The Medical University of Vienna and Vienna General Hospital perform the first two commercial implants worldwide of Sequana Medical’s alfapump system.
New technology expands treatment options for patient with refractory ascites due to liver cirrhosis.
NovaShunt AG has launched a new corporate identity and product branding to support its goal of leadership in the area of fluid management within the body. The company will now operate as Sequana Medical AG (www.sequanamedical.com) as it prepares for the upcoming launch of the alfapump system in Europe.